Placebo controlled fMRT assessment of the effects of the cannabinoid receptor agonist dronabinol (THC) on pain associated brain activation

Trial Profile

Placebo controlled fMRT assessment of the effects of the cannabinoid receptor agonist dronabinol (THC) on pain associated brain activation

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Tetrahydrocannabinol (Primary)
  • Indications Acute pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Jul 2012 Status changed from recruiting to completed as reported by German Clinical Trials Register.
    • 06 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top